December 06, 2019
tami sin youtube  twitter facebook

    CIC’s Life-Saving Kidney Dialysis Product

    October 14, 2014

    The Pharmaceutical department of CIC’s Healthcare division is creating a significant impact in Sri Lanka’s healthcare sector by providing people with a simple and convenient kidney dialysis product. The peritoneal dialysis product distributed by CIC Pharmaceuticals is the only dialysis treatment of its kind available in Sri Lanka. The product is developed by Baxter USA, a global healthcare company with expertise in medical devices, pharmaceuticals and biotechnology.

    There are two prevalent types of kidney diseases, the first is Chronic Kidney Disease (CKD) and the second is End Stage Renal/Kidney Disease (ESRD). Whilst the first occurs over a longer period of time due to a variety of reasons including hypertension, the latter occurs when the kidneys are almost non-functional. It is estimated that out of every one million people in South East Asia, at least 120 suffer from kidney disease. In Sri Lanka, it is believed that there are approximately 2500 kidney patients suffering from End Stage Renal/Kidney Disease and 7500-8000 patients suffering from Chronic Kidney Disease. There has also been an increase in the number of cases being diagnosed in the North and Central provinces.

    The peritoneal dialysis product is designed to treat and assist kidney patients suffering from ESRD. For most of these patients, only five to ten percent of their kidneys remain functional, so toxins remain trapped in their bodies. The peritoneal dialysis product drains out all water and toxins accumulated within the body due to a failing kidney and replaces it with fluids required by the body. Fourteen days prior to the treatment commencing, patients have to undergo a minor surgical procedure to insert a catheter into the peritoneal cavity.

    The peritoneal dialysis product is simple and easy to use; it’s also a life-saving solution that enhances the quality of life for patients suffering from kidney disease. Unlike hemodialysis which involves removing toxins from the blood and treatments lasting up to four hours, peritoneal dialysis is a simple and effective home therapy which only needs to be done three times a day for fifteen minutes at a time. With peritoneal dialysis, there is no need to travel regularly to a hospital so patients can reduce both their transport costs and the amount of time they spend in hospital. The peritoneal dialysis product can be used in the comfort of a patient’s home or office, providing valuable freedom and mobility. Following the insertion of a catheter, a patient only needs to invest in the fluids for the treatment. The catheter and adapter are designed to remain intact for life however the transfer set needs to be changed every six months to prevent infection. Peritoneal dialysis ensures that the kidneys do not deteriorate further; this prevents the need for kidney replacement.

    CIC has also worked extensively with the government sector and leading hospitals to familiarize staff with the peritoneal dialysis solution. CIC’s Healthcare division is a pioneer in Sri Lanka’s healthcare industry. Through a variety of business operations, CIC Holdings remains dedicated to its goal of nurturing life and improving the quality of people’s lives in Sri Lanka. The company continuously impacts people through its extensive portfolio which extends into the areas of agriculture, animal feed, nutrition, healthcare, industrial materials, and consumer products.(KH)

    dgi log front

    recu

    electionR2

    Desathiya